241 related articles for article (PubMed ID: 17322541)
21. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
22. Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.
Chen BT; Loberg RD; Neeley CK; O'Hara SM; Gross S; Doyle G; Dunn RL; Kalikin LM; Pienta KJ
Urology; 2005 Mar; 65(3):616-21. PubMed ID: 15780403
[TBL] [Abstract][Full Text] [Related]
23. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
24. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
[TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
26. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
27. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
Xu T; Lu B; Tai YC; Goldkorn A
Cancer Res; 2010 Aug; 70(16):6420-6. PubMed ID: 20663903
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.
Stott SL; Lee RJ; Nagrath S; Yu M; Miyamoto DT; Ulkus L; Inserra EJ; Ulman M; Springer S; Nakamura Z; Moore AL; Tsukrov DI; Kempner ME; Dahl DM; Wu CL; Iafrate AJ; Smith MR; Tompkins RG; Sequist LV; Toner M; Haber DA; Maheswaran S
Sci Transl Med; 2010 Mar; 2(25):25ra23. PubMed ID: 20424012
[TBL] [Abstract][Full Text] [Related]
29. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.
Moreno JG; O'Hara SM; Gross S; Doyle G; Fritsche H; Gomella LG; Terstappen LW
Urology; 2001 Sep; 58(3):386-92. PubMed ID: 11549486
[TBL] [Abstract][Full Text] [Related]
30. Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy.
Lowes LE; Lock M; Rodrigues G; D'Souza D; Bauman G; Ahmad B; Venkatesan V; Allan AL; Sexton T
Clin Transl Oncol; 2012 Feb; 14(2):150-6. PubMed ID: 22301405
[TBL] [Abstract][Full Text] [Related]
31. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene.
Schmidt H; DeAngelis G; Eltze E; Gockel I; Semjonow A; Brandt B
Cancer Res; 2006 Sep; 66(18):8959-65. PubMed ID: 16982734
[TBL] [Abstract][Full Text] [Related]
32. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
[TBL] [Abstract][Full Text] [Related]
33. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
[TBL] [Abstract][Full Text] [Related]
34. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
35. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
36. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
[TBL] [Abstract][Full Text] [Related]
37. Sample-to-Answer Isolation and mRNA Profiling of Circulating Tumor Cells.
Mohamadi RM; Ivanov I; Stojcic J; Nam RK; Sargent EH; Kelley SO
Anal Chem; 2015 Jun; 87(12):6258-64. PubMed ID: 26009151
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
Doyen J; Alix-Panabières C; Hofman P; Parks SK; Chamorey E; Naman H; Hannoun-Lévi JM
Crit Rev Oncol Hematol; 2012 Mar; 81(3):241-56. PubMed ID: 21680196
[TBL] [Abstract][Full Text] [Related]
39. Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
Ju M; Kao GD; Steinmetz D; Chandrasekaran S; Keefe SM; Guzzo TJ; Christodouleas JP; Hahn SM; Dorsey JF
Cancer Biol Ther; 2014 Jun; 15(6):683-7. PubMed ID: 24618718
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression.
Palermo G; Bassi P; Racioppi M; Recupero SM; Sacco E; Campetella M; Canu G; Pinto F
Minerva Urol Nefrol; 2020 Apr; 72(2):214-222. PubMed ID: 31144490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
